Cargando…
Impact of effective prevention and management of febrile neutropenia
Chemotherapy-induced febrile neutropenia is costly in both financial and human terms. The associated costs can be reduced substantially through the development and implementation of national policies and locally agreed protocols for the prevention and management of febrile neutropenia. Patients, the...
Autores principales: | Krell, D, Jones, A L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752228/ https://www.ncbi.nlm.nih.gov/pubmed/19756004 http://dx.doi.org/10.1038/sj.bjc.6605273 |
Ejemplares similares
-
Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009) -
Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009) -
Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
por: Kelly, S, et al.
Publicado: (2009) -
Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014) -
Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)